ZANNETTI, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 405
AS - Asia 173
EU - Europa 162
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 742
Nazione #
US - Stati Uniti d'America 392
SG - Singapore 74
IT - Italia 65
CN - Cina 52
VN - Vietnam 38
NL - Olanda 18
IE - Irlanda 15
SE - Svezia 15
UA - Ucraina 14
DE - Germania 12
CA - Canada 11
FI - Finlandia 8
GB - Regno Unito 6
KR - Corea 3
RU - Federazione Russa 3
IN - India 2
JP - Giappone 2
BG - Bulgaria 1
BR - Brasile 1
CR - Costa Rica 1
EU - Europa 1
FR - Francia 1
HU - Ungheria 1
MK - Macedonia 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
Totale 742
Città #
Chandler 91
Singapore 57
Dong Ket 38
Santa Clara 33
Ashburn 28
Napoli 26
Beijing 23
Amsterdam 18
Jacksonville 14
Boston 13
Des Moines 12
Naples 12
Princeton 10
Millbury 9
Nanjing 8
Wilmington 8
Ottawa 7
Lawrence 6
Guangzhou 5
Seattle 5
Absecon 3
Boardman 3
Houston 3
Nanchang 3
Rome 3
Woodbridge 3
Dallas 2
Dublin 2
Falkenstein 2
Florence 2
Hebei 2
Jiaxing 2
Kronberg 2
Milan 2
Montréal 2
Moscow 2
Munich 2
Nutley 2
Pune 2
Tianjin 2
Tokyo 2
Alexandria 1
Atlanta 1
Boulder 1
Budapest 1
Chengdu 1
Covilha 1
Ferrara 1
Ghotki 1
Helsinki 1
Imola 1
Kunming 1
Königsbronn 1
Maidenhead 1
Manila 1
Marseille 1
Mexico 1
Nagold 1
North Brunswick 1
Norwalk 1
Nuremberg 1
Salerno 1
San Diego 1
San José 1
Seoul 1
Shenyang 1
Shenzhen 1
Skopje 1
Sofia 1
Toronto 1
Washington 1
Winnipeg 1
Wuhan 1
Totale 503
Nome #
Cross-talk between bone marrow-derived mesenchymal stem cells and tumor cells: role of cxcr4 and aqp1 in osteosarcoma and hepatocarcinoma progression. 103
Aquaporin 1 and CXCR4 expression in human and sheep mesenchymal stem cells 99
Novel and Selective avb3 Receptor Peptide Antagonist: Design, Synthesis, and Biological Behavior 57
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors 49
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 48
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion 45
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer 44
Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype 43
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells 42
Autocrine signals increase Ovine Mesenchymal Stem Cells migration throughAquaporin-1 and CXCR4 overexpression 42
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis 42
Bone Marrow-Derived Mesenchymal Stem Cells Promote Growth and Migration of Osteosarcoma and Hepatocarcinoma Cells through CXCR4 and AQP1 41
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer 36
Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT 35
Expression of aquaporin-1 and cxcr4 in ovine mesenchymal stem cell. 30
Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression 27
The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function 19
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells 3
Totale 805
Categoria #
all - tutte 3.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 0 2 4 0 5 18 3
2020/2021113 2 6 18 4 3 8 6 4 7 14 3 38
2021/2022115 4 0 2 1 1 3 0 3 13 14 37 37
2022/2023187 19 30 3 14 23 23 2 12 33 16 9 3
2023/202481 5 15 5 5 8 17 1 2 0 0 19 4
2024/2025116 20 41 6 2 16 31 0 0 0 0 0 0
Totale 805